ABOUT US / MILLESTONE

MILLESTONE

MILESTONE

2003athe CHEMO Group start up branded pharmaceutical business in Europe after acquiring 50% of EFFIK, a specialist company in gynaecology.

 

MILESTONE

2005aStrategic alliance open the door to Asia through sinensix Pharma (Thailand, Vietnam), to Russia and CIS countries with new BC Pharma subsidiary and to Mexico thanks to Elea Mexico.

MILESTONE

2008aGrowth continues in Asia with Chemo Wanbang Biopharma and Chemway.Agreement to market a novel, unique treatment for diabetic foot.

 

MILESTONE

2009athe company increases its production capacity in america by joining the US market through Everett Labs and the group members, Altian Pharma (Central America), VyT Pharma(Pharaguay), Everett (USA). its presence in Europe expands to the largest market, Germany, through Velvian, as well as to Poland and Eastern Europe, when it was already present with TemaPharm y Ladee Pharma, respectively.

MILESTONE

2012aConsolidation of South-East Asian market with Nufarindo (Indonesia) and Exeltis Malaysia, start of operations in India with a new partner, Ordain, and the addition of Austria and Switzerland to the European market with Velvian and Veldana, respectively. Its American operations are strengthened with Eticos (Paraguay).

MILESTONE

2013athe company Arrives in Africa with the acquisition of Athéa Pharma, Specifically in the Moroccan Market with special emphasis on women’s Health, in which we are a company of reference. Evolution and sustained growth in the branded Pharmaceuticals market leads to the creation of Exeltis. Exeltis consolidate its presence in the United State, it has acquired 100% of Quinnova Pharmaceuticals, a US company specializing in a wide variety of dermatological products.

MILESTONE

2014aExeltis has acquired 100% of the Turkish pharmaceutical Embil. The deal is the Biggest acquisition ever by Exeltis aboard. the deal is part of Exeltis’s Strategic Plan that aims to consolidate its international development

MILESTONE

2015aExeltis continues broadening tha large family. its starts activities in Chile and strengthens its position in India through the acquisition of women’s health division, specialized in fertility products.